LAUREN MAUPIN: Open Payments
NPI 1568965846 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,480 in 161 payments from 23 companies in 2025. Trend: 2023 $2,331 · 2024 $5,078 · 2025 $6,480
Food & beverage: $4,920Honoraria: $1,200Education: $360
| Company | Payments | Amount |
|---|---|---|
| LNHC, Inc | 1 | $1,200 |
| Janssen Biotech, Inc. | 24 | $940 |
| ABBVIE INC. | 25 | $907 |
| Galderma Laboratories, L.P. | 13 | $584 |
| Regeneron Healthcare Solutions, Inc. | 14 | $456 |
| Arcutis Biotherapeutics, Inc. | 13 | $368 |
| Novartis Pharmaceuticals Corporation | 13 | $293 |
| Amgen Inc. | 12 | $289 |
| GENZYME CORPORATION | 10 | $274 |
| UCB, Inc. | 6 | $227 |
Products named: ZELSUVMI, TREMFYA, DUPIXENT, SKYRIZI, NEMLUVIO, Zoryve, OTEZLA, Bimzelx.
Industry payments across KY — which companies pay providers there.
